AGLNYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
agilon health, inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$88.83+3.71 (+4.36%)
Close on Oct 19, 2026
- Market cap
- $1.53B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$64.83 (+270.2%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
agilon health, inc. grew revenue 0.3% to $5.92B over the twelve months to Jun 30, 2026. Free cash flow was -$84.95M.
Revenue
$5.92B
+0.3% vs. a year earlier
Operating income
-$309.33M
TTM Q2 2026
Free cash flow
-$84.95M
TTM Q2 2026
EPS, diluted
-$14.06
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.53B
- P/E ratio
- –
- Price to sales
- 0.26
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -5.56%
Fundamentals
- Revenue
- $5.92B
- Net income
- -$232.22M
- EPS, diluted
- -$14.06
- Free cash flow
- -$84.95M
- Diluted shares
- 17M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$5.92B+0.3% YoY
Operating income
-$309.33M
Net income
-$232.22M
EPS, diluted
-$14.06
Free cash flow
-$84.95M
Reported periodTrailing twelve months